Goodman Tony 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Aug 2, 2018
Insider Transaction Report
Form 4
Goodman Tony
DirectorChief Operating Officer
Transactions
- Purchase
Common Stock
2018-07-31+7,000→ 8,755 total - Purchase
Warrant to purchase common stock
2018-07-31+7,000→ 7,000 totalExercise: $6.25From: 2018-07-31Exp: 2023-07-31→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]On July 31, 2018, the reporting person purchased 7,000 units (the "Units") in the initial public offering (the "IPO") of Adial Pharmaceuticals, Inc. (the "Company") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO.